Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET. - Wikidata - awgldk - TriplyDB

Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET.

Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET.

http://www.wikidata.org/entity/Q43942287

about

Imaging metabolic heterogeneity in cancer Molecular and functional imaging technology for the development of efficient treatment strategies for gliomas.Post-treatment imaging changes in primary brain tumors.Imaging biomarkers in primary brain tumours.Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.Imaging in neurooncology Detecting tumor progression in glioma: Current standards and new techniques.The value of positron emission tomography and proliferation index in predicting progression in low-grade astrocytomas of childhood.[11C]-L-methionine positron emission tomography in the management of children and young adults with brain tumors.3'-Deoxy-3'-[(18)F]fluorothymidine and O-(2-[(18)F]fluoroethyl)-L-tyrosine PET in Patients with Suspicious Recurrence of Glioma after Multimodal Treatment: Initial Results of a Retrospective Comparative Study Anaplastic astrocytoma mimicking progressive multifocal leucoencephalopathy: a case report and review of the overlapping syndromes Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practice.Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors.2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology.PET Imaging in Patients with Meningioma - Report of the RANO/PET Group.Differentiation of Brain Tumor Recurrence from Post-Radiotherapy Necrosis with 11C-Methionine PET: Visual Assessment versus Quantitative Assessment Serial O-(2-[(18)F]fluoroethyl)-L: -tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas.Simultaneous 11C-Methionine Positron Emission Tomography/Magnetic Resonance Imaging of Suspected Primary Brain Tumors.Positron emission tomography: clinical applications in oncology. Part 2.Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma.Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomography Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI.Evaluation of the biodistribution of 11C-methionine in children and young adults.An automated voxel-based method for calculating the reference value for a brain tumour metabolic index using 18F-FDG-PET and 11C-methionine PET.Imaging with non-FDG PET tracers: outlook for current clinical applications.Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.A comparison study of (11)C-methionine and (18)F-fluorodeoxyglucose positron emission tomography-computed tomography scans in evaluation of patients with recurrent brain tumors.Comparision of F-18 FDG and C-11 Methionine PET/CT for demonstration of subependymal deposit in a treated case of glioblastoma multiforme [ (11) C]-methionine positron emission tomography in the postoperative imaging and followup of patients with primary and recurrent gliomas.Rapid and efficient synthesis of [11C]ureas via the incorporation of [11C]CO2 into aliphatic and aromatic amines.18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.The performance of 11C-Methionine PET in the differential diagnosis of glioma recurrence.Visual and semiquantitative 11C-methionine PET: An independent prognostic factor for survival of newly diagnosed and treatment naive gliomas.Positron emission tomography imaging in gliomas: applications in clinical diagnosis, for assessment of prognosis and of treatment effects, and for detection of recurrences.Prognostic value of volume-based measurements on (11)C-methionine PET in glioma patients.How treatment monitoring is influencing treatment decisions in glioblastomas.Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging.

P2860

Q28076500-D64E58E2-1DED-4844-B158-C9916488A118 Q30775012-D134A69F-F8B5-4B85-8652-4579672FED36 Q30835236-BDE182E4-BEB2-4347-9013-20EE34168234 Q30880129-6F9E14B5-9712-4754-80E7-D218C2479CA5 Q30907831-ACC57CB2-B005-4967-A0D7-75CC934D1790 Q30989939-B9D4FA34-E8D5-4076-9589-38387CF9C840 Q31132701-05D781F2-7F29-467D-9FD4-63E1F90625F5 Q33464358-5C36FEC7-C87A-4AF3-955F-79191DF0BE66 Q33599162-DF0CBDD8-FAF3-4350-AC0C-80CE1B9CB84C Q33704202-15E68C01-D5D6-416D-A5E4-81C51889D26D Q33814485-1969A4BD-DBDA-4535-AFB4-21ED15DFE867 Q33838502-A5443BC4-5082-44BF-97A4-EF34BFA02948 Q33862844-18562640-EA50-45ED-BDB0-7195DE266633 Q34348544-DE54D18B-352B-4F8B-B3D5-38775F102246 Q34404416-1D5361C2-48B0-4C0F-913F-6E220CC6B809 Q34682187-B028B273-B763-483B-AC1E-E4FA36F8849C Q35689330-99D53191-427A-43EB-B1D4-8BBEB21395AA Q36021392-38D60E7C-B639-4CCA-9045-A26B7F311C13 Q36107379-BBC194E6-5D72-4609-A094-6B50546A69D3 Q36210293-4704D948-6D3A-4F3A-86E6-DF1EF7EF801E Q36448703-C29DC301-CB31-4E71-B910-6112AA6E88FD Q36474762-079D7071-4CF8-4640-81CC-0B408424C3FC Q37235829-C409A8DA-0094-4B19-B50E-802F9EC80025 Q37432387-ABF6EAC4-1CE4-4ECD-B554-8DDB9B15FE16 Q37584750-64592797-3A02-4631-9F22-F1F8A8001E94 Q37703206-B31482E3-4520-402A-8F52-C36EF125614B Q37986065-BBC17EB7-D8D8-49D7-BA27-09FFCD7239E3 Q38074638-C0A97430-42F6-48F6-AEF4-7DCD5E5FE20E Q38815396-1E9EBAD1-1FD7-4881-BE48-44054EC0F456 Q39724277-8580170F-9CA2-4A77-9E64-6A7B56160530 Q39771049-3467775B-988F-4298-B37A-79C0B3578C70 Q41871381-A209D8EB-A43D-41DF-9BC4-AAAA425EF355 Q43776076-43291AB2-D899-44E6-B7A0-FF3C93EE5662 Q46366163-540CBB7C-D890-4ECE-829A-C3AFA591DA07 Q47114149-8621E436-39C8-4756-AE02-DD83D34800E0 Q47583631-0D3D4304-78A0-4B10-A732-89BBA8A747F2 Q48158155-EB4DEBBF-8D15-479E-BFF0-F3E4F670D8C0 Q48241629-AD84C89F-FC7F-462E-970F-C7EC1060CEC6 Q48292017-A5595AEF-7AF3-4E10-8AF6-C1A1440B4F04 Q48346347-30D0E117-CCD7-4538-AF23-BF1741FEBEF6

P2860

Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET.

http://www.wikidata.org/entity/Q43942287

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Usefulness of 11C-methionine P ...... r isometabolic on 18F-FDG PET.

@en

Usefulness of 11C-methionine P ...... r isometabolic on 18F-FDG PET.

@nl

type

label

Usefulness of 11C-methionine P ...... r isometabolic on 18F-FDG PET.

@en

Usefulness of 11C-methionine P ...... r isometabolic on 18F-FDG PET.

@nl

prefLabel

Usefulness of 11C-methionine P ...... r isometabolic on 18F-FDG PET.

@en

Usefulness of 11C-methionine P ...... r isometabolic on 18F-FDG PET.

@nl

P1433

Q43942287-B0F8D974-FD52-4012-AA10-F7ADE0412BB6

P1476

Q43942287-A773DE16-C9D8-419B-ABAF-81163CD95B18

P2093

Q43942287-1C48DF52-9CD3-451B-9123-CB35FD7D4F58

Q43942287-5057E62C-093B-4095-84E0-E80ADBDB0463

Q43942287-5239141E-E8B3-4C1A-A698-062DCF4AFD8C

Q43942287-5FA85B33-4997-477B-BC83-9FA3B4C9435D

Q43942287-67870027-718C-4B06-9BF9-B9EAEA4D23FE

Q43942287-6CD1C745-C163-4E5D-B2AA-9923EF467837

Q43942287-86C25F48-6123-4696-8A70-D7E2B197EDCB

Q43942287-8DED2FA0-1DF5-4811-9FBE-528513C8C0EF

Q43942287-9C056109-D606-45E1-83E7-C8D0AD6567A4

Q43942287-D5C0E838-6CC9-44D1-932E-5C1E96CAD5C1

P2888

Q43942287-AC1E95A9-38A6-4CA6-8A20-DBC5F7BD35C0

P304

Q43942287-7C8D960B-7EA9-458B-B937-F9C940C05CDB

P31

Q43942287-50497BAA-BB3F-47CE-AC68-E37B41C88CAD

P356

Q43942287-C3A55D16-2406-405D-8E0A-178460EC4512

P433

Q43942287-EC2C2B03-639A-42D2-BCC4-5279738CF45F

P478

Q43942287-E54F0F5C-F746-4804-9C12-630E49DE4BCD

P577

Q43942287-D190160F-7806-48AF-A6EE-32632A7CF71D

P698

Q43942287-F064E391-996A-499A-AB50-FF9507629366

P356

S00259-001-0690-4

P1433

European Journal of Nuclear Medicine and Molecular Imaging

P1476

Usefulness of 11C-methionine P ...... r isometabolic on 18F-FDG PET.

@en

P2093

Dong Soo Lee

http://www.w3.org/2001/XMLSchema#string

Hee Won Jung

http://www.w3.org/2001/XMLSchema#string

Jae Min Jeong

http://www.w3.org/2001/XMLSchema#string

Jeong Seok Yeo

http://www.w3.org/2001/XMLSchema#string

June-Key Chung

http://www.w3.org/2001/XMLSchema#string

Myung Chul Lee

http://www.w3.org/2001/XMLSchema#string

Seok-ki Kim

http://www.w3.org/2001/XMLSchema#string

Suntta Paek

http://www.w3.org/2001/XMLSchema#string

Yong Jin Lee

http://www.w3.org/2001/XMLSchema#string

Yu Kyeong Kim

http://www.w3.org/2001/XMLSchema#string

P2888

s00259-001-0690-4

P304

176-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-001-0690-4

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11926379

http://www.w3.org/2001/XMLSchema#string